All Access Articles |
- Keros Therapeutics to Return $375M to Shareholders | 2025-10-15 | PHARMACEUTICAL
- Keros Therapeutics Presents Positive Phase 1 Clinical Trial Data | 2025-09-08 | PHARMACEUTICAL
- Keros Therapeutics Initiates Strategic Review for Stockholder Value | 2025-04-10 | PHARMACEUTICAL
- Keros Therapeutics Announces $200M Agreement with Takeda | 2025-01-21 | PHARMACEUTICAL
- Keros Therapeutics Appoints Chief Medical Officer | 2024-10-16 | PHARMACEUTICAL